Metro Mining’s Bauxite Hills mine reserves double to 96.5 million tonnes

Published 18-JAN-2017 17:24 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Metro Mining (ASX: MMI) announced on Wednesday morning that its bauxite reserves for its Bauxite Hills project located in the Cape York Peninsula region of Queensland had doubled to 96.5 million tonnes.

This follows the inclusion of measured, indicated and inferred resources of direct shipping ore from the Skardon River Bauxite Project, recently purchased by Metro Mining via the acquisition of Gulf Alumina.

Analysts at Argonaut noted in December that the acquisition of Gulf Alumina would extend Metro’s mine life, enable higher production and expedite final permitting. Furthermore, the broker estimates that synergies of up to $200 million can be realised as a result of the circa $40 million acquisition which was part funded by major shareholder Greenstone Resources.

The broker also said that additional scale gives Metro market relevance and improves its appeal to offtake parties. Metro has already negotiated a binding offtake agreement for 7 million tonnes per annum with Xinfa Group. The company also benefits from Gulf’s existing infrastructure, including an airstrip, haul roads and a barge loadout site.

Argonaut estimates production of 3 million tonnes per annum will generate EBITDA of $81 million.

While Metro had previously released a Definitive Feasibility Study (DFS) for a 2 million tonnes per annum operation which was superseded by a Prefeasibility Study (PFS) for a 4 million tonnes per annum operation, Argonaut now believes the company will target an initial 3 million tonnes per annum, ramping up to 6 million tonnes per annum.

The broker estimates that such a project could generate EBITDA of circa $81 million on a 3 million tonnes per annum case. This is broadly in line with the group’s enterprise value based on Wednesday morning’s opening price of 14.5 cents.

Metro’s project is strategically located with its landholding of 2500 square kilometres the second-largest in the Gulf province behind Rio Tinto.

It should be noted that broker projections and price targets are only estimates and may not be met. Also, historical data in terms of earnings performance and/or share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

Industry sources anticipate a substantial increase in demand for bauxite both in the near and medium-term as seen here:

MMI Metro Mining Bauxite Chinese demand

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free